Revisions Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Singapore S.E.
Equities
T14
CNE100000924
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.99 USD | 0.00% | 0.00% | -3.86% |
04-30 | Tianjin Pharmaceutical's Q1 Profit, Revenue Fall 3% | MT |
04-30 | Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Recommends Dividend | CI |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
- Stock Market
- Equities
- 600329 Stock
- T14 Stock
- Revisions Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited